Press releases

For the first time in Europe, Tübingen physicians make use of an RNA therapy specifically tailored to one patient

Press release in German only

Press contact

Director of Communications

Silke DutzTelefon 07071 29 88802silke.dutz@medizin.uni-tuebingen.deAddress

Hertie Institute for Clinical Brain Research

Otfried-Müller-Str. 27
72076 Tübingen

One mutation - one medicine